where too this week?, page-5

GSK and the unnamed FMCG announced further agreements and and a letter of intent 8 and 18 days after 3M made its first MTA extension public, in early Feb.

At that time I found these prompt announcements to be a direct answer of the other 2 companies towards 3M to indicate that 3M has competition.

It will be interesting to see if this is repeated this time round.

The time frame of the latest extension of the MTA gives every acting party more leeway in their approach of possible deals with OBJ.
That could be a good thing for OBJ as more partners can come to the table but it also puts a possible strain onto share price as market would not see any immediate action necessary from any of the involved players.

But then again, OBJ is known to surprise everybody, its your best guess what will happen.

There are clear signs of stabilization of the share price and OBJ is in the process to find its bottom from where it usually strongly bounces off.